Metabiota Appoints Distinguished Data Scientist and Disease Modeler as CEO

Share Article

Leader in Infectious Disease Risk Solutions Announces Nita Madhav to Lead Next Phase of Company Growth

News Image
With over fourteen years of experience in probabilistic modeling and risk assessment, Nita has an extensive background in building teams, fostering innovation and developing models that provide actionable insights to commercial and government entities.

Today, Metabiota, the global pioneer in infectious disease risk solutions, announced the appointment of Nita Madhav as the company's next Chief Executive Officer, and its first female officer. Nita has most recently served as Metabiota’s Vice President of Data Science, where she led the data science department for the past 3.5 years.

“This is a pivotal time for the company, and it comes on the heels of substantial strides, including the establishment of key partnerships with Munich Re, In-Q-Tel, Inc. (IQT), Marsh, and the African Risk Capacity,” said Madhav. “Metabiota will continue to focus on developing and deploying our novel solutions that improve the world’s resilience to epidemic risk, and I am honored to step into this role and to help usher in the next phase of company growth.”

Prior to Metabiota, Madhav worked as a Principal Scientist at AIR Worldwide, where she led the life and health research and modeling team. Prior to that, she performed hantavirus research at the Special Pathogens Branch of the US Centers for Disease Control and Prevention.

“With over fourteen years of experience in probabilistic modeling and risk assessment, Nita has an extensive background in building teams, fostering innovation and developing models that provide actionable insights to commercial and government entities,” said Ryan Philips, Metabiota board member and Principal at WP Global Partners. “Nita has the deep technical knowledge and company and market expertise to build on Metabiota’s momentum.”

Madhav holds a BS in Ecology & Evolutionary Biology, with distinction, from Yale University and an MSPH in Epidemiology from the Rollins School of Public Health at Emory University.

For more information on Metabiota, visit http://www.metabiota.com.

About Metabiota
Metabiota is the pioneer in comprehensive risk analytics that help organizations and countries build resilience to epidemics and protect global public health. Built on a strong foundation of scientific expertise, including a worldwide network of on-the-ground experts, Metabiota delivers actionable, data-driven analytics to help countries and corporations mitigate complex health issues. With a strategic global presence and sustained partnerships, Metabiota’s agile approach helps identify, analyze and transfer the risk associated with biological threats. The company’s international footprint includes operations in nearly 20 countries and offices in San Francisco, Canada, Cameroon and the Democratic Republic of the Congo. For more information, visit http://www.metabiota.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Aimee Eichelberger
Visit website